The prediction models for postoperative overall survival and disease-free survival in patients with breast cancer

Author:

Shigemizu Daichi1234,Iwase Takuji5,Yoshimoto Masataka6,Suzuki Yasuyo7,Miya Fuyuki12,Boroevich Keith A2,Katagiri Toyomasa89,Zembutsu Hitoshi10,Tsunoda Tatsuhiko123ORCID

Affiliation:

1. Department of Medical Science Mathematics; Medical Research Institute; Tokyo Medical and Dental University; Tokyo Japan

2. Laboratory for Medical Science Mathematics; RIKEN Center for Integrative Medical Sciences; Yokohama Japan

3. CREST; Japan Science and Technology Agency; Tokyo Japan

4. Department for Medical Genome Sciences; Medical Genome Center; National Center for Geriatrics and Gerontology; Obu Japan

5. Department of Breast Surgical Oncology; Breast Oncology Center; Cancer Institute Hospital; Japanese Foundation for Cancer Research; Tokyo Japan

6. Yoshimoto Breast Clinic; Tokyo Japan

7. First Department of Surgery; Sapporo Medical University; School of Medicine; Sapporo Japan

8. Division of Genome Medicine; Institute for Genome Research; Tokushima University; Tokushima Japan

9. Human Genome Center; Institute of Medical Science; The University of Tokyo; Tokyo Japan

10. Division of Genetics; National Cancer Center Research Institute; Tokyo Japan

Publisher

Wiley

Subject

Cancer Research,Radiology, Nuclear Medicine and imaging,Oncology

Reference41 articles.

1. American Cancer Society Cancer facts and figures 2015 https://www.cancer.org/content/dam/cancer-org/research/cancer-facts-and-statistics/annual-cancer-facts-and-figures/2015/cancer-facts-and-figures-2015.pdf

2. Lipid-based nanocarriers for breast cancer treatment - comprehensive review;Talluri;Drug Deliv.,2015

3. The benefit of HER2-targeted therapies on overall survival of patients with metastatic HER2-positive breast cancer - a systematic review;Mendes;Breast Cancer Res.,2015

4. Overall survival, disease-free survival, local recurrence, and nipple-areolar recurrence in the setting of nipple-sparing mastectomy: a meta-analysis and systematic review;Cruz;Ann. Surg. Oncol.,2015

5. Management of bone loss in postmenopausal breast cancer patients treated with aromatase inhibitors;Cepa;Acta Reumatol. Port.,2015

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3